Old Web
English
Sign In
Acemap
>
Paper
>
Safety and Efficacy of adding pegylated Interferon–α2b to standard Dose Dasatinib in newly diagnosed CP-CML
Safety and Efficacy of adding pegylated Interferon–α2b to standard Dose Dasatinib in newly diagnosed CP-CML
2015
Henrik Hjort-Hansen
Jepser Stentoft
Johan Richter
Perttu Koskenvesa
Stina Söderlund
Arta Dreimane
Kimmo Porkka
Tobias Gedde-Dahl
Bjørn Tore Gjertsen
Franz X. Gruber
Leif Stenke
Kristina Myhr-Eriksson
Berit Markevärn
Hanne Vestergaard
Lene Udby
Ole Weis Bjerrum
Satu Mustjoki
Ulla Olsson-Strömberg
Keywords:
Dasatinib
Cancer research
Pegylated interferon
Medicine
Oncology
newly diagnosed
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]